PMID- 33125828
OWN - NLM
STAT- MEDLINE
DCOM- 20210514
LR  - 20210514
IS  - 1529-8019 (Electronic)
IS  - 1396-0296 (Linking)
VI  - 33
IP  - 6
DP  - 2020 Nov
TI  - Alendronate induced subacute cutaneous lupus erythematosus successfully treated 
      with intravenous immunoglobulin.
PG  - e14477
LID - 10.1111/dth.14477 [doi]
AB  - The subacute cutaneous lupus erythematosus (SCLE) is a distinct subtype of lupus 
      erythematosus (LE) representing specific clinical and serological features. 
      Almost 20%-30% of the cases with SCLE are predicted to associated with 
      medications. Thiazide diuretics, terbinafine, antiepileptic, and proton pump 
      inhibitors are the best-known drugs to induce drug-related SCLE. Herein we want 
      to present a 65-year-old female with alendronate induced SCLE, resistant to 
      classical therapies, and respond well to intravenous immunoglobulin (IVIG), 
      suggesting that IVIG could be an alternative treatment in patients resistant to 
      classical treatment protocols.
CI  - (c) 2020 Wiley Periodicals LLC.
FAU - Uzuncakmak, Tugba Kevser
AU  - Uzuncakmak TK
AUID- ORCID: 0000-0001-8057-3463
AD  - Department of Dermatology, Cerrahpasa Medical Faculty, Istanbul University, 
      Istanbul, Turkey.
FAU - Bayazit, Samet
AU  - Bayazit S
AD  - Department of Dermatology, Cerrahpasa Medical Faculty, Istanbul University, 
      Istanbul, Turkey.
FAU - Askin, Ozge
AU  - Askin O
AUID- ORCID: 0000-0003-1413-9436
AD  - Department of Dermatology, Cerrahpasa Medical Faculty, Istanbul University, 
      Istanbul, Turkey.
FAU - Engin, Burhan
AU  - Engin B
AD  - Department of Dermatology, Cerrahpasa Medical Faculty, Istanbul University, 
      Istanbul, Turkey.
FAU - Ugurlu, Serdal
AU  - Ugurlu S
AD  - Department of Rheumatology, Cerrahpasa Medical Faculty, Istanbul University, 
      Istanbul, Turkey.
FAU - Sar, Mehmet
AU  - Sar M
AD  - Department of Pathology, Cerrahpasa Medical Faculty, Istanbul University, 
      Istanbul, Turkey.
FAU - Serdaroglu, Server
AU  - Serdaroglu S
AD  - Department of Dermatology, Cerrahpasa Medical Faculty, Istanbul University, 
      Istanbul, Turkey.
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20201105
PL  - United States
TA  - Dermatol Ther
JT  - Dermatologic therapy
JID - 9700070
RN  - 0 (Immunoglobulins, Intravenous)
RN  - X1J18R4W8P (Alendronate)
SB  - IM
MH  - Aged
MH  - Alendronate/adverse effects
MH  - Female
MH  - Humans
MH  - Immunoglobulins, Intravenous
MH  - *Lupus Erythematosus, Cutaneous/chemically induced/diagnosis/drug therapy
MH  - *Lupus Erythematosus, Systemic
OTO - NOTNLM
OT  - dapsone
OT  - dermatology
OT  - dermatopathology
OT  - discoid lupus
OT  - intravenous immunoglobulin
OT  - mycophenolate mofetil
OT  - subacute cutaneous lupus erythematosus
EDAT- 2020/10/31 06:00
MHDA- 2021/05/15 06:00
CRDT- 2020/10/30 17:16
PHST- 2020/09/02 00:00 [received]
PHST- 2020/10/07 00:00 [revised]
PHST- 2020/10/26 00:00 [accepted]
PHST- 2020/10/31 06:00 [pubmed]
PHST- 2021/05/15 06:00 [medline]
PHST- 2020/10/30 17:16 [entrez]
AID - 10.1111/dth.14477 [doi]
PST - ppublish
SO  - Dermatol Ther. 2020 Nov;33(6):e14477. doi: 10.1111/dth.14477. Epub 2020 Nov 5.